Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay Tetzlaff

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Experimental Cell Research|September 23, 2010
In vivo inhibition of epidermal growth factor receptor autophosphorylation prevents receptor internalizationMichael Wolff, Kay Tetzlaff, Michael C Nivens, et al.
Respiratory Medicine|December 21, 2016
Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary diseaseRoland Buhl, Sheldon Magder, Ulrich Bothner, et al.
Pulmonary Pharmacology & Therapeutics|May 10, 2015
The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary diseaseKai-Michael Beeh, Jan Westerman, Anne-Marie Kirsten, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 1, 2016
Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary diseaseRoberto Rodriguez-Roisin, Kay Tetzlaff, Henrik Watz, et al.
Respiratory Medicine|July 30, 2008
Development and validation of a cough and sputum assessment questionnaireBruce Crawford, Brigitta Monz, Jens Hohlfeld, et al.
European Journal of Applied Physiology|November 27, 2008
Hypoxia and cardiac arrhythmias in breath-hold divers during voluntary immersed breath-holdsJochen Hansel, Isabelle Solleder, Wilfried Gfroerer, et al.
Respiratory Research|December 15, 2018
Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trialHenrik Watz, Kay Tetzlaff, Helgo Magnussen, et al.
Therapeutic Advances in Respiratory Disease|February 15, 2018
Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary diseaseFrançois Maltais, Denis O'Donnell, Juan Bautista Gáldiz Iturri, et al.
American Journal of Respiratory and Critical Care Medicine|June 23, 2016
The 6-Minute-Walk Distance Test as a Chronic Obstructive Pulmonary Disease Stratification Tool. Insights from the COPD Biomarker Qualification ConsortiumBartolome Celli, Kay Tetzlaff, Gerard Criner, et al.
Respiratory Medicine|January 31, 2014
Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationaleHelgo Magnussen, Henrik Watz, Anne Kirsten, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Experimental Cell Research|September 23, 2010
In vivo inhibition of epidermal growth factor receptor autophosphorylation prevents receptor internalizationMichael Wolff, Kay Tetzlaff, Michael C Nivens, et al.
Respiratory Medicine|December 21, 2016
Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary diseaseRoland Buhl, Sheldon Magder, Ulrich Bothner, et al.
Pulmonary Pharmacology & Therapeutics|May 10, 2015
The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary diseaseKai-Michael Beeh, Jan Westerman, Anne-Marie Kirsten, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 1, 2016
Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary diseaseRoberto Rodriguez-Roisin, Kay Tetzlaff, Henrik Watz, et al.
Respiratory Medicine|July 30, 2008
Development and validation of a cough and sputum assessment questionnaireBruce Crawford, Brigitta Monz, Jens Hohlfeld, et al.
European Journal of Applied Physiology|November 27, 2008
Hypoxia and cardiac arrhythmias in breath-hold divers during voluntary immersed breath-holdsJochen Hansel, Isabelle Solleder, Wilfried Gfroerer, et al.
Respiratory Research|December 15, 2018
Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trialHenrik Watz, Kay Tetzlaff, Helgo Magnussen, et al.
Therapeutic Advances in Respiratory Disease|February 15, 2018
Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary diseaseFrançois Maltais, Denis O'Donnell, Juan Bautista Gáldiz Iturri, et al.
American Journal of Respiratory and Critical Care Medicine|June 23, 2016
The 6-Minute-Walk Distance Test as a Chronic Obstructive Pulmonary Disease Stratification Tool. Insights from the COPD Biomarker Qualification ConsortiumBartolome Celli, Kay Tetzlaff, Gerard Criner, et al.
Respiratory Medicine|January 31, 2014
Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationaleHelgo Magnussen, Henrik Watz, Anne Kirsten, et al.
Pageof 7